丰倍生物
(603334)
| 流通市值：14.43亿 | | | 总市值：66.67亿 |
| 流通股本：3105.36万 | | | 总股本：1.44亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,251,405,158.14 | 1,478,129,194.9 | 1,948,016,326.78 | 1,387,043,687.06 |
| 营业收入 | 2,251,405,158.14 | 1,478,129,194.9 | 1,948,016,326.78 | 1,387,043,687.06 |
| 二、营业总成本 | 2,150,718,766.31 | 1,403,179,057.94 | 1,831,430,204.2 | 1,299,401,861.35 |
| 营业成本 | 2,048,471,846.61 | 1,337,752,954.4 | 1,720,659,550.01 | 1,219,308,975.58 |
| 税金及附加 | 8,321,868.46 | 5,498,628.03 | 5,119,682.87 | 2,704,884.48 |
| 销售费用 | 14,099,991.68 | 9,011,097.94 | 21,810,250.8 | 14,959,342.52 |
| 管理费用 | 24,460,138.66 | 15,129,104.23 | 29,065,633.53 | 21,368,288.95 |
| 研发费用 | 51,128,748.5 | 34,447,089.74 | 53,566,132.33 | 37,211,288.4 |
| 财务费用 | 4,236,172.4 | 1,340,183.6 | 1,208,954.66 | 3,849,081.42 |
| 其中:利息费用 | 4,831,755.99 | 3,372,078.11 | 5,998,351.1 | 4,606,556.46 |
| 其中:利息收入 | 524,394.27 | 403,647.4 | 720,116.22 | 683,715.51 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 191,871.01 | 225,846.75 | -340,708.35 | -90,028.61 |
| 加:投资收益 | -444,144.69 | -366,401.17 | 290,222.44 | 434,759.68 |
| 资产处置收益 | 729.51 | 729.51 | 48,776.73 | 3,893.17 |
| 资产减值损失(新) | -800,186.49 | -755,770.82 | -734,567.77 | -690,203.87 |
| 信用减值损失(新) | -4,058,782.25 | -3,558,359.08 | -4,813,425.23 | -4,690,839.23 |
| 其他收益 | 32,209,434.29 | 23,138,706.37 | 20,290,679.43 | 11,379,300.48 |
| 四、营业利润 | 127,785,313.21 | 93,634,888.52 | 131,327,099.83 | 93,988,707.33 |
| 加:营业外收入 | 20,298.54 | 13,532.28 | 3,221,152.66 | 3,166,743.97 |
| 减:营业外支出 | 111,781.7 | 75,120.05 | 127,882.84 | 72,984.17 |
| 五、利润总额 | 127,693,830.05 | 93,573,300.75 | 134,420,369.65 | 97,082,467.13 |
| 减:所得税费用 | 10,395,003.57 | 8,509,992.17 | 10,600,489.67 | 10,401,222.26 |
| 六、净利润 | 117,298,826.48 | 85,063,308.58 | 123,819,879.98 | 86,681,244.87 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 117,298,826.48 | 85,063,308.58 | 123,819,879.98 | 86,681,244.87 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 117,298,826.48 | 85,063,308.58 | 123,819,879.98 | 86,681,244.87 |
| 扣除非经常损益后的净利润 | 116,678,526.48 | 84,702,672.51 | 115,319,089.85 | 78,474,044.87 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.09 | 0.79 | 1.15 | 0.81 |
| (二)稀释每股收益 | 1.09 | 0.79 | 1.15 | 0.81 |
| 九、综合收益总额 | 117,298,826.48 | 85,063,308.58 | 123,819,879.98 | 86,681,244.87 |
| 归属于母公司股东的综合收益总额 | 117,298,826.48 | 85,063,308.58 | 123,819,879.98 | 86,681,244.87 |
| 公告日期 | 2025-11-04 | 2025-08-15 | 2025-06-30 | 2025-10-17 |
| 审计意见(境内) | | 标准无保留意见 | 标准无保留意见 | |